Search results
Jeong Heo. Professor of Internal Medicine, College of Medicine, Pusan National University. Verified email at pusan.ac.kr. Hepatology Gastroenterology GI Oncology.
Jeong Heo currently works at the Department of Internal Medicine, Pusan National University. Jeong does research in Hepatology, Oncology and Clinical Trials.
Jul 5, 2023 · OBP-301 is an oncolytic adenovirus modified to replicate within cancer cells and lyse them. This open-label, non-comparative, phase I dose-escalation trial aimed to assess its safety and optimal dosage in 20 patients with advanced hepatocellular carcinoma.
JX-594 is a targeted and granulocyte-macrophage colony stimulating factor (GM-CSF) expressing oncolytic poxvirus designed to selectively replicate in and destroy cancer cells through viral oncolysis and tumor-specific immunity. In a phase 1 trial, JX-594 injection into hepatocellular carcinoma (HCC) was well-tolerated and associated with viral ...
- Jeong Heo, Caroline J Breitbach, Anne Moon, Chang Won Kim, Rick Patt, Mi Kyung Kim, Yu Kyung Lee, Su...
- 2011
May 1, 2024 · The benefit of 5-FU/platinum with anti-PD-1 in first-line advanced gastric cancer is limited to patient subgroups. Using a trial with sequential anti-PD-1, we show coordinated induction of multicellular TME hubs informs the ability of anti-PD-1 to potentiate T cell-driven responses. Differential TME ….
May 1, 2024 · Abstract. Adding anti–programmed cell death protein 1 (anti–PD-1) to 5-fluorouracil (5-FU)/platinum improves survival in some advanced gastroesophageal adenocarcinomas (GEA). To understand the effects of chemotherapy and immunotherapy, we conducted a phase II first-line trial ( n = 47) sequentially adding pembrolizumab to 5-FU/platinum in ...
People also ask
Who is Jeong Heo?
What is “Hyo jeong”?
Who is Jeong HyeonWoo?
Who is Jeong Yoon hee?
Jan 24, 2016 · Jeong Heo currently works at the Department of Internal Medicine, Pusan National University. Jeong does research in Hepatology, GI Oncology and Clinical.
